Novalis Biotech is a venture capital group focused on seed-stage bioinformatics, diagnostics, digital health, and genomics companies with an emphasis on critical future growth areas.
Novalis was founded by Jan Van den Berghe and Wim Van Criekinge in 2018. Since then, it closed its first fund, Novalis Biotech Acceleration (Fund I). That fund, which raised...